Ann Arbor, Michigan 48109


Purpose:

This study will fill a scientific gap in the current knowledge providing data for evaluation of the palatal augmentation prosthesis as a therapeutic modality in a robust scientific randomized prospective clinical trial. Positive outcomes from this study have the potential to dramatically alter the most common morbidity of oral cancer therapy, namely speech and swallowing function in a population of patients with T1/T2 tumors of the tongue who are not currently routinely recommended for a palatal augmentation prosthesis.


Criteria:

Inclusion Criteria: - Patients with a new diagnosis of a T1/T2 tongue cancer Exclusion Criteria: - Patients with recurrent disease - Patients with a history of prior head and neck radiation therapy - Patients who lack adequate maxillary dentition to support a palatal augmentation prosthesis


NCT ID:

NCT02584270


Primary Contact:

Principal Investigator
Stephanie M Munz, DDS
University of Michigan

Stephanie M Munz, DDS
Phone: 734 936-8289
Email: smmunz@med.umich.edu


Backup Contact:

Email: jalay@med.umich.edu
Jennifer A Lay-Luskin, MPhil, CCRC


Location Contact:

Ann Arbor, Michigan 48109
United States

Stephanie Munz, DDS
Phone: 734-936-8289
Email: smmunz@med.umich.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.